stockrowStrata Critical Medical, Inc. (SRTA) vs Starling Oncology, Inc. (STLN)
- Strata Critical Medical, Inc. SRTA 5.57 +5.89%
- Starling Oncology, Inc. STLN 3.51 −47.61%
Strata Critical Medical, Inc. and Starling Oncology, Inc. are both Medical Care Facilities companies. Starling Oncology, Inc. is the larger, with a market value of $669.9M against $469.8M — 1.4× the size. Strata Critical Medical, Inc. grew revenue faster over the last twelve months: 68.4% against 34.6%. Starling Oncology, Inc. has the higher net margin (−5.73% vs −8.84%) and the higher return on invested capital (0.00% vs −4.96%). Across the 17 metrics below, Starling Oncology, Inc. leads on 10 and Strata Critical Medical, Inc. on 7.
Valuation
Profitability
| Metric | SRTA | STLN | Medical Care Facilities median |
|---|---|---|---|
| Gross margin | 21.57% | 0.00% | 30.56% |
| Operating margin | (6.63%) | (3.39%) | 6.62% |
| Net margin | (8.84%) | (5.73%) | 3.08% |
| Free cash flow margin | (0.14%) | 3.03% | 7.22% |
| Return on equity | (8.87%) | 143.21% | 6.41% |
| Return on assets | (7.47%) | (20.23%) | 2.78% |
| Return on invested capital | (4.96%) | 0.00% | 7.44% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack